Menu

Recipients of Experimental Herpes Vaccine File Lawsuit

The suit claims that Rational Vaccines, the company of recently deceased researcher William Halford, violated US and international laws when it carried out the procedure.

Mar 15, 2018
Catherine Offord

ISTOCK, BERNARDASVThree people who developed adverse side effects after receiving injections of an unapproved, experimental herpes vaccine have taken the matter to court, according to a lawsuit filed on Friday (March 9) in Illinois (via Kaiser Health News). Southern Illinois University researcher William Halford, who was responsible for the creation of the vaccine and the injections themselves, died last summer, but the recipients of his vaccine are claiming compensation from his company, Rational Vaccines, which they claim violated US and international laws that protect the rights of study participants.

“My clients are anxious to ensure such unethical experimentation on human subjects are not repeated,” Alan Milstein, a New Jersey lawyer who is representing the three participants, tells Kaiser Health News. The suit requests compensation for both the costs of medical care and for the “pain and suffering” and loss of dignity incurred by the participants.

Two of the procedures mentioned in the suit were carried out in 2016 as part of an unsanctioned trial in the Caribbean island nation St. Kitts and Nevis that included testing on 20 people. “The Ministry of Health states categorically that neither the Cabinet, the Ministry of Health, the office of Chief Medical Officer nor the St. Kitts and Nevis Medical Board has ever been approached on this project,” the country’s government noted afterwards (via Kaiser Health News). “By extension, none of these agencies has approved such a venture.”

The third procedure was performed in a hotel in Illinois, without the oversight of the US Food and Drug Administration (FDA). Kaiser Health News notes that Rational Vaccines, which Halford cofounded with filmmaker Agustín Fernández III in 2015, has not responded to request for comment on the most recent development, but has previously said it plans to continue testing the vaccine and working toward eventual FDA approval.

Meanwhile, Southern Illinois University is proceeding with a misconduct investigation relating to Halford’s research, and possible complicity among his colleagues.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.